関連レポート

　バイオインフォマティクスの世界市場：製品サービス別、用途別2026年予測

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

出版元：BCC Research　 出版元について

発行年：2022年1月

定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

ご請求は円換算（お見積り日TTSレート）となります。

納品形態：PDF by Email

当調査レポートは英文138ページになります。

商品コード：BCC368

【レポート紹介】

バイオバンクの世界市場規模は2021年で611億ドル、2026年に762億ドル、市場の平均年成長率は4.5%で推移する見込みです。
2000年以降バイオバンク数は著しく増加しています。この要因として、十分に注釈がつけられた高品質の生物試料と、治療/診断開発プログラムのためのオミクスが豊富なデータセットに対する需要増加が挙げられます。また、10億を超えるサンプルが世界中の1000を超えるバイオバンクに保管されていると推定されています。これは、ゲノミクス、メタゲノミクス、プロテオミクス、個別化医療、疾患生物学、公衆衛生分野でのバイオバンクサンプルの需要増加に起因するでしょう。他に成長推進要因としては、バイオバンクに対する民間/政府機関からの資金増加、ゲノム研究活動の増加、および様々なヘルスケア企業による研究開発活動への投資増加なども挙げられます。

当レポートでは、バイオバンクの市場/技術的背景、世界中の現在のバイオバンク、市場機会分析各種セグメント別市場分析(サンプルタイプ別、用途別、オーナータイプ別、国地域別)、特許レビュー/最新の進展、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術的背景

・バイオバンクのプロセス
・バイオバンクの分類
・バイオバンクの応用
・バイオバンクのユーザー
・バイオバンキングのコスト

◆世界中の現在のバイオバンク

・北米の主要バイオバンク
・北米のバイオバンクをサポートする主要インフラストラクチャ
・欧州の主要バイオバンク
・欧州のバイオバンクをサポートする主要インフラストラクチャ
・アジア太平洋の主要バイオバンク
・アジア太平洋のバイオバンクをサポートする主要インフラストラクチャ
・その他地域の主要バイオバンク

◆市場機会分析

・ドライバー
・障壁
・世界のバイオバンク業界のSWOT分析
・COVID-19による影響

◆バイオバンク市場、サンプルタイプ別

・生体液
・組織
・幹細胞
・DNA/RNA
・その他
※市場予測データ-2026年掲載

◆バイオバンク市場、用途別

・バイオバンク用途（基礎科学研究、臨床）
※市場予測データ-2026年掲載

◆バイオバンク市場、地域別

・バイオバンク北米市場
・バイオバンク欧州市場
・バイオバンクアジア太平洋市場
・バイオバンクその他地域市場
※市場予測データ-2026年掲載
※用途別のデータ掲載
※地域ごとに主要国別のデータ掲載

◆バイオバンク市場、オーナータイプ別

・政府機関/公共部門プロバイダー
・学術機関/大学
・非営利組織
・民間組織
※市場予測データ-2026年掲載

◆特許レビュー/最新の進展

・特許レビュー
・最新の進展

◆主要企業プロフィール

・AGILENT TECHNOLOGIES INC.
・AMGEN, INC.
・ASTRAZENECA PLC
・AVANTOR INC.
・AZENTA LIFE SCIENCES
・BIOKRYO GMBH
・BRUKER CORP.
・CENTOGENE N.V.
・HAMILTON CO.
・INDIVUMED GMBH
・MERCK KGAA
・QIAGEN N.V.
・TECAN GROUP LTD.
・THERMO FISHER SCIENTIFIC INC.

(全138頁)

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Scope of Report
Methodology and Information Sources
What's New in This Report?
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Key Highlights

Chapter 3 Market and Technology Background

Biobank Overview
The Process of Biobanking
Classification of Biobanks
Disease-Oriented/Clinical Based Biobanks
Population-Based Biobanks
Applications of Biobanks
Users of Biobanks
Biobanking Costs

Chapter 4 Current Biobanks Worldwide

Overview
Leading Biobanks in North America

• All of Us Research Program
• National Cancer Institute (NCI)
• The National Heart, Lung and Blood Institute (NHLBI) Biologic Specimen and Data Repository
• Kaiser Permanente Research Bank
• The University of Mississippi Medical Center (UMMC)
• The AIDS and Cancer Specimen Resource (ACSR)
• National Institute of General Medical Sciences (NIGMS) Human Genetic Cell Repository
• BioMe Biobank
• Canadian Partnership for Tomorrow Project (CanPath)

Leading Infrastructure That Supports Biobanking in North America
Leading Biobanks in Europe

• The U.K. Biobank
• Biobank Graz
• The International Agency for Research on Cancer (IARC) Biobank
• Danish National Biobank
• FinnGen
• Estonian Biobank
• deCODE Genetics

Leading Infrastructure that Supports Biobanking in Europe

• BBMRI-ERIC
• EuroBioBank Network
• RD-Connect

Leading Biobanks in the Asia-Pacific Region

• Biobank Japan
• Victorian Cancer Biobank
• China Kadoorie Biobank
• Shanghai Zhangjiang Biobank

Leading Infrastructure that Supports Biobanking in the Asia-Pacific Region
Leading Biobanks in the Rest of World

• The Qatar Biobank

Chapter 5 Analysis of Market Opportunities

Market Drivers

• Increasing Public Funding in Biobank Projects
• Increasing Applications in Drug Discovery and Development
• Increasing Pharmaceutical and Biotech R&D Spending
• Developments in Analytical Technologies and Assay Methods
• Growing Focus on Mainstream Precision Medicine and Rise of Genomic Medicine/Clinical Genomics
• Biobanking Technique Advancements
• Growing Private Biobanking

Market Restraints

• Legal and Ethical Challenges
• Sustainability
• Lack of Standardization/Harmonization
• Insufficient Awareness About Biobanking Activities

SWOT Analysis of Global Biobanking Industry
Impact of COVID-19

Chapter 6 Market Breakdown by Sample Type

Overview
Biofluids
Tissues
Stem Cells
DNA/RNA
Others

• Market Size and Forecast
• Market Analysis

Chapter 7 Market Breakdown by Application

Overview
Biobanking Applications

• Basic/Scientific Research
• Clinical Research/Therapeutics

Chapter 8 Market Breakdown by Region

Global Market for Biobanking by Region
North American Market for Biobanking

• Market Analysis
• Market Revenue by Application
• Market Revenue by Country

European Market for Biobanking

• Market Analysis
• Market Revenue by Application
• Market Revenue by Country

Asia-Pacific Market for Biobanking

• Market Analysis
• Market Revenue by Application
• Market Revenue by Country

Rest of the World Market for Biobanking

• Market Analysis
• Market Revenue by Application
• Market Revenue by Sub-region

Chapter 9 Market Breakdown by Ownership Type

Overview
Government Agencies/Public Sector Providers
Academic Institutes/Universities
Nonprofit Organizations
Private Organizations

• Market Size and Forecast
• Market Analysis

Chapter 10 Patent Review/New Developments

Patent Review
New Developments

Chapter 11 Company Profiles

AGILENT TECHNOLOGIES INC.
AMGEN, INC.
ASTRAZENECA PLC
AVANTOR INC.
AZENTA LIFE SCIENCES
BIOKRYO GMBH
BRUKER CORP.
CENTOGENE N.V.
HAMILTON CO.
INDIVUMED GMBH
MERCK KGAA
QIAGEN N.V.
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.

Chapter 12 Appendix: Acronyms

List of Tables

Summary Table : Global Market for Biobanking, by Ownership Type, Through 2026
Table 1 : Selected Cancer-Specific Biobanks
Table 2 : Selected Population-Based Biobanks
Table 3 : Types of Biobanks Listed on BBMRI-ERIC Database
Table 4 : Number of Studies That Obtained/Used Biospecimens in Clinical Trials, by Funder Type
Table 5 : Leading Global Biobanks/Projects
Table 6 : Selected National Cancer Institute Biobanking Infrastructure
Table 7 : Selected Biobanks in North America
Table 8 : Selected Infrastructure that Supports Biobanking in the U.S.
Table 9 : Selected Biobanks Based in the European Region
Table 10 : BBMRI Services
Table 11 : BBMRI Projects Launched in 2020
Table 12 : Biobanks and Standalone Collection Centers Associated with BBMRI-ERIC
Table 13 : Share of Composite Funding Methods for Biobanks in BBMRI Countries
Table 14 : Selected Biobanks Based in the Asia-Pacific Region
Table 15 : Selected Infrastructure that Supports Biobanking in Asia-Pacific Countries
Table 16 : Genomics Platforms and Applications
Table 17 : Selected Biobanks Focused on Genome Based Research Projects
Table 18 : Selected International Infrastructures/Organizations Supporting the Development of Harmonized Platforms for Biobanks
Table 19 : Selected Large Biobanks Contributing to COVID-19 Research
Table 20 : Global Market for Biobanking, by Sample Type, Through 2026
Table 21 : Oncology Studies Utilizing Tissue Samples
Table 22 : Types of Biomarkers Based on Their Applications
Table 23 : Biomarkers: Drug Development
Table 24 : Applications of Biobank in Cancer Treatment
Table 25 : Global Market for Biobanking, by Application, Through 2026
Table 26 : Clinical Trials Initiated between 2015 and 2021, by Condition
Table 27 : Global Market for Biobanking, by Region, Through 2026
Table 28 : North American of Biobanking Studies, by Funder Type
Table 29 : North American Market for Biobanking, by Application, Through 2026
Table 30 : North American Market for Biobanking, by Country, Through 2026
Table 31 : Selected Biospecimen Based Scientific Initiatives in Europe
Table 32 : European Market for Biobanking, by Application, Through 2026
Table 33 : European Market for Biobanking, by Country, Through 2026
Table 34 : Demographic and Healthcare Statistics for Selected European Countries
Table 35 : Asia-Pacific Market for Biobanking, by Application, Through 2026
Table 36 : Asia-Pacific Market for Biobanking, by Country, Through 2026
Table 37 : RoW Market for Biobanking, by Application, Through 2026
Table 38 : RoW Market for Biobanking, by Sub-region, Through 2026
Table 39 : Selected Government-Owned Biobanks
Table 40 : Selected Academic Institutes/University Owned Biobanks
Table 41 : Selected Nonprofit Organization-Owned Biobanks
Table 42 : Selected Private Biobank Organizations
Table 43 : Global Market for Biobanking, by Ownership Type, Through 2026
Table 44 : Patents Issued on Biobanking Techniques, 2015-2021
Table 45 : Selected Biobanking Studies, 2018-2021
Table 46 : Clinical Trials Initiated between 2015 and 2021 Involving Biobanks, by Therapeutic Area
Table 47 : Hamilton: Automated Sample Management Solutions
Table 48 : Qiagen: Biobanking Portfolio
Table 49 : Thermo Fisher Scientific: Biobanking Solutions
Table 50 : Acronyms Used in the Global Biobanking Industry

List of Figures

Summary Figure A : Global Market for Biobanking, by Ownership Type, 2019-2026
Summary Figure B : Global Market Shares of Biobanking, by Ownership Type, 2020
Figure 1 : Some Common Aims of Biobanks
Figure 2 : Biobank Sample/Data Types
Figure 3 : Flow of Biospecimens and Data Through the Biobanking Infrastructure
Figure 4 : Number of Clinical Trials Using Biospecimens, 2014-2021
Figure 5 : Places that Create/Use Biobanks
Figure 6 : Distribution of Operating Costs for Academic Biobanks
Figure 7 : Genetic Data Release Timeline, the U.K. Biobank
Figure 8 : Share of FinnGen Expenditure for the First Three Years of the Study, 2020
Figure 9 : Publications Referencing Biobanking, 2011-2021
Figure 10 : Drug Development Cost Statistics and Trends
Figure 11 : Share of Biobanks Collaboration on BBMRI-ERIC Database, by Type
Figure 12 : SWOT Analysis of Global Market for Biobanking
Figure 13 : Global Market for Biobanking, by Sample Type, 2019-2026
Figure 14 : Global Market Shares of Biobanking, by Sample Type, 2020
Figure 15 : Biospecimens Paving the Way for Personalized Theory
Figure 16 : Global Market for Biobanking, by Application, 2019-2026
Figure 17 : Global Market Shares of Biobanking, by Application, 2020
Figure 18 : Global Market for Biobanking, by Region, 2019-2026
Figure 19 : Global Market Shares of Biobanking, by Region, 2020
Figure 20 : North American Market for Biobanking, by Application, 2019-2026
Figure 21 : North American Market for Biobanking, by Country, 2019-2026
Figure 22 : European Market for Biobanking, by Application, 2019-2026
Figure 23 : European Market for Biobanking, by Country, 2019-2026
Figure 24 : Top Three Areas of Expertise of Germany Biobanking Ecosystem
Figure 25 : Top Three Areas of Expertise of the U.K. Biobanking Ecosystem
Figure 26 : Top Three Areas of Expertise of the Netherlands Biobanking Ecosystem
Figure 27 : Health Expenditures per Capita for Selected European Countries, 2015-2019
Figure 28 : Asia-Pacific Market for Biobanking, by Application, 2019-2026
Figure 29 : Asia-Pacific Market for Biobanking, by Country, 2019-2026
Figure 30 : Health Expenditures per Capita for Selected Asia-Pacific Countries, 2015-2019
Figure 31 : RoW Market for Biobanking, by Application, 2019-2026
Figure 32 : RoW Market for Biobanking, by Sub-region, 2019-2026
Figure 33 : Global Market for Biobanking, by Ownership Type, 2019-2026
Figure 34 : Global Market Shares of Biobanking, by Ownership Type, 2020
Figure 35 : Clinical Trials on Biobanking, 2015-2021
Figure 36 : Agilent: Annual Revenue, 2018-2020
Figure 37 : Agilent: Revenue Share, by Segment, 2020
Figure 38 : Amgen: Annual Revenue, 2018-2020
Figure 39 : AstraZeneca: Annual Revenue, 2018-2020
Figure 40 : Avantor: Annual Revenue, 2018-2020
Figure 41 : Azenta Life Sciences: Annual Revenue, 2018-2020
Figure 42 : Bruker: Annual Revenue, 2018-2020
Figure 43 : Bruker: Revenue Share, by Segment, 2020
Figure 44 : Centogene: Annual Revenue, 2018-2020
Figure 45 : Centogene: Revenue Share, by Segment, 2020
Figure 46 : Merck: Annual Revenue, 2018-2020
Figure 47 : Qiagen: Annual Revenue, 2018-2020
Figure 48 : Tecan: Annual Revenue, 2018-2020
Figure 49 : Thermo Fisher Scientific: Annual Revenue, 2018-2020
Figure 50 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020